The government has missed a chance to better target cost cuts to certain patient groups, for certain medical conditions, and for generic drugs.
Academic rigour, journalistic flair
Articles on PBS
Displaying 1 - 20 of 64 articles
Changes in the latest federal budget will mostly affect people who need multiple medicines throughout the year, perhaps for chronic disease. But there are other ways to reduce drug costs.
People who need the most health care – the poor and the chronically ill – miss out on care the most. But there are ways to reduce this inequity.
A trend towards including more diverse characters has changed children’s television, but there’s still work to be done, especially when it comes to gender and representation.
The Pharmacy Guild represents the owners of community pharmacies around the country. Their reach into every community and large political donations make them more powerful than other lobby groups.
Labor and the Coalition’s health policies and campaign strategy couldn’t be more different this election.
Here’s how the Turnbull/Morrison government performed on hospitals, primary care, pharmaceuticals and private health insurance.
The EU is asking Australia to extend drug company monopolies. This could mean Australians wait longer for access to cheaper, generic medicines.
Without credible news and information, a healthy democracy is not possible.
There are more than 30 different types of contraceptive pills. But brand names such as Microgynon, Levlen, Yaz and Brenda give little indication of the ingredients, dose or who should use them.
The HIV prevention drug Truvada (PrEP) will be listed on the Pharmaceutical Benefits Scheme from this Sunday, moving Australia closer to achieving its goal of ending new HIV transmissions by 2020.
It’s exciting to think we’re on the brink of a genomic revolution in health care. But just because new technology becomes available, it doesn’t mean it should automatically be publicly funded.
Some argue the current system of subsidising drugs in Australia needs changing to accommodate new cancer therapies. But two recent drug listings show the current system is working perfectly well.
Have you ever wondered why some drugs are so cheap, and others so expensive? Here’s why.
How, why and when do people lie – and what happens as a result?
Australia has been subsidising drugs to cure hepatitis C since March 2016. Unlike in many other countries, these are available to everyone with the disease and are much cheaper for our government.
Cyntoia Brown was just 16 years old when she shot and killed a man in 2004. Under Tennessee law, she won’t be eligible for parole until she is 67 years old. Is such a harsh sentence constitutional?
The fund is nothing more than a rebadging exercise in the hope people might think it is a new policy. And it’s being used to airbrush public hospitals out of the Medicare picture.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
When the Corporation for Public Broadcasting was founded 50 years ago, it was supposed to reflect the nation’s disparate voices.
Job Board
-
Executive Director, Office of VC & President
-
Deputy Dean, Faculty of Design, Architecture and Building
-
Research Engineer
-
Deputy Dean, Education and Employability with the Faculty of Science and Engineering
-
Development Associate
Top contributors
-
Stephen Duckett is a Friend of The Conversation.Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice, The University of Melbourne
-
Professor of Health Economics, The University of Melbourne
-
ARC Future Fellow, Australian National University
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Journalism, Media and Communication, Queensland University of Technology
-
Professor of Health Economics, Flinders University
-
Dean, University of Wollongong
-
Associate Professor in Public Health, La Trobe University
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Senior Research Fellow, University of Technology Sydney
-
Research Fellow, Flinders University
-
Professor of Health Economics, The University of Melbourne
-
Professor, Kirby Institute, UNSW Sydney
-
Adjunct Associate Professor, Menzies Centre for Health Policy, University of Sydney
-
Adjunct Professor, Murdoch University
